- Home
- CRML vs ACTU Comparison
CRML vs ACTU Comparison
Compare CRML & ACTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRML
- ACTU
- Stock Information
- Founded
- CRML N/A
- ACTU 2015
- Country
- CRML United States
- ACTU United States
- Employees
- CRML N/A
- ACTU 10
- Industry
- CRML
- ACTU
- Sector
- CRML
- ACTU
- Exchange
- CRML NYSE
- ACTU NYSE
- Market Cap
- CRML 146.8M
- ACTU 154.3M
- IPO Year
- CRML N/A
- ACTU 2024
- Fundamental
- Price
- CRML $1.40
- ACTU $7.90
- Analyst Decision
- CRML
- ACTU Strong Buy
- Analyst Count
- CRML 0
- ACTU 1
- Target Price
- CRML N/A
- ACTU $20.00
- AVG Volume (30 Days)
- CRML 776.1K
- ACTU 37.3K
- Earning Date
- CRML 02-01-2025
- ACTU 05-21-2025
- Dividend Yield
- CRML N/A
- ACTU N/A
- EPS Growth
- CRML N/A
- ACTU N/A
- EPS
- CRML N/A
- ACTU N/A
- Revenue
- CRML $476,979.00
- ACTU N/A
- Revenue This Year
- CRML N/A
- ACTU N/A
- Revenue Next Year
- CRML N/A
- ACTU N/A
- P/E Ratio
- CRML N/A
- ACTU N/A
- Revenue Growth
- CRML 326.80
- ACTU N/A
- 52 Week Low
- CRML $1.32
- ACTU $5.51
- 52 Week High
- CRML $14.00
- ACTU $11.73
- Technical
- Relative Strength Index (RSI)
- CRML 28.86
- ACTU N/A
- Support Level
- CRML $1.32
- ACTU N/A
- Resistance Level
- CRML $1.93
- ACTU N/A
- Average True Range (ATR)
- CRML 0.20
- ACTU 0.00
- MACD
- CRML 0.10
- ACTU 0.00
- Stochastic Oscillator
- CRML 8.37
- ACTU 0.00
About CRML CRITICAL METALS CORPORATION
Critical Metals Corp is engaged in lithium exploration in Austria. It is focused on the development of its wholly-owned Wolfsberg Lithium Project (the Wolfsberg Project) located in Carinthia, Austria.
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.